Mr. Arthur is a senior life sciences executive with more than 25 years of U.S. and global experience leading medical and marketing organizations in product development as well as launching and managing pharmaceutical and device brands. Prior to Decoy Therapeutics, Mr. Arthur was Managing Director of Dacon Pharma. Additionally, He spent more than 20 years with Eli Lilly and Boehringer-Ingelheim in executive roles managing product development, business development, U.S. brands, global commercialization, European regional marketing and financial planning/analysis.
Mr. Arthur earned a B.S. in Chemical Engineering from North Carolina State University, a Master of Business Administration from Duke University, Fuqua School of Business and is a licensed Professional Engineer and Six Sigma Green Belt.